Public Citizen letter cited in STAT News report on Biogen’s Alzheimer’s drug

By Ed Silverman

In a scathing letter to the Office of Inspector General at the Department of Health and Human Services, the Public Citizen advocacy group accused the FDA of “unbridled enthusiasm” for the medicine and for pursuing “unprecedented” cooperation with the biotech company, which has “dangerously compromised the independence and objectivity” of FDA senior staff and clinical reviewers.

Read the whole story here.